Claims

Nurse-led biologics practices improve monitoring, therapy appropriateness, and quality of life while reducing costs

Claim · All claims
Evidence · 1 study · review r2 · q2
Currency · newest study 2025 · not yet checked against its sources · not reviewed by a person

Subclaims

Reading the evidence codes

q is the design tier, i the impact, n the sample, and the kind with its r the rigour judged within that kind: what each code means.

This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.

q2 i? The review reports that nurse-led biologic practices enhance patient monitoring, therapy appropriateness, and quality of life while reducing medication costs. → Li Wansheng 2025

Evidence

Li Wansheng 2025

Li Wansheng, Li Li, Li Linbo, Xiaodong Cardenas, Chen Mudiao, Liu Hongye, Li Peirao. (2025). Competencies of nurses to participate in safe medication management practices for biologics: A scoping review. PLoS ONE. https://doi.org/10.1371/journal.pone.0317750

q2 · i? · review · r2

This is the review authors' synthesis of the background literature, reported as a narrative claim rather than a pooled estimate. The authors state that "The literature indicates that nurse-led biologic practices enhance patient monitoring, therapy appropriateness, and quality of life while reducing medication costs."

"The literature indicates that nurse-led biologic practices enhance patient monitoring, therapy appropriateness, and quality of life while reducing medication costs."

Discussion

Page metadata
Field Value
status review
generated by process:wiki-ingest on 2026-10-31
trust unverified — no one has confirmed this page's content

Frontmatter is the page's machine-readable record — see the Schema & Guide.